MASTERINVEST Kapitalanlage’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$530K Buy
9,194
+97
+1% +$5.57K 0.05% 216
2026
Q1
$552K Buy
9,097
+1,677
+23% +$97.8K 0.06% 208
2025
Q4
$402K Sell
7,420
-11,221
-60% -$540K 0.04% 223
2025
Q3
$841K Sell
18,641
-62,410
-77% -$2.91M 0.08% 192
2025
Q2
$3.75M Buy
+81,051
New +$3.98M 0.39% 61

Other funds holding BMY

MASTERINVEST Kapitalanlage's BMY Position: Q2 2026 in Review

MASTERINVEST Kapitalanlage increased its Bristol-Myers Squibb (BMY) stake by 1.1% in Q2 2026, buying an estimated $5.57K and bringing the position to 9,194 shares worth $530K. The position accounts for 0.05% of the portfolio, ranked #216.

MASTERINVEST Kapitalanlage first reported a position in BMY in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.75M in Q2 2025. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • MASTERINVEST Kapitalanlage held 9,194 shares of Bristol-Myers Squibb worth $530K as of Q2 2026.
  • MASTERINVEST Kapitalanlage bought 97 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.57K.
  • Bristol-Myers Squibb made up 0.05% of MASTERINVEST Kapitalanlage's portfolio in Q2 2026, its #216 holding.
  • MASTERINVEST Kapitalanlage first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 5 quarters since.
  • MASTERINVEST Kapitalanlage's Bristol-Myers Squibb position peaked at $3.75M in Q2 2025.
  • 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on MASTERINVEST Kapitalanlage's 13F filing for Q2 2026, filed 17 Aug 2026.